u.s. chemist is charged with insider stock trades
the chemist, cheng yi liang, and his son are accused of using confidential agency data about pending drug approvals to make profitable trades.
http://feeds.nytimes.com/click.phdo?i=22490f662305eb2c3e33b26f5c5e44ef
8955
30 Mar 2011 21:30:59
nyt
business